CATX
CATX
AMEX · Biotechnology

Perspective Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$2.88
+0.00 (+0.00%)
As of Sep 20, 10:25 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +583.0% upside
Low Target $12.33
Average Target $19.67
High Target $23.14
Current Price $2.88
Current
$2.88
Target
$19.67
$12.33 $19.67 avg $23.14
Scenario Analysis
Bear Case
$12.33
328.1%
Low target
Base Case
$19.67
+583.0%
Avg target
Bull Case
$23.14
+703.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$6.16
-53.2% from high
52-Week Low
$1.96
+46.9% from low
Target vs 52W High
$19.67
+219.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%